Request for Covid-19 Impact Assessment of this Report
The United States Blood Pressure Disorders Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Blood Pressure Disorders Drug market, reaching US$ million by the year 2028. As for the Europe Blood Pressure Disorders Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Blood Pressure Disorders Drug players cover A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, and Actelion Pharmaceuticals Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Pressure Disorders Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hypertension
Hypotension
Pulmonary Hypertension
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial - Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Pressure Disorders Drug Market Size 2017-2028
2.1.2 Blood Pressure Disorders Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Blood Pressure Disorders Drug Segment by Type
2.2.1 Diuretics
2.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
2.2.3 Angiotensin Receptor Blockers (ARBs)
2.2.4 Others
2.3 Blood Pressure Disorders Drug Market Size by Type
2.3.1 Blood Pressure Disorders Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Blood Pressure Disorders Drug Market Size Market Share by Type (2017-2022)
2.4 Blood Pressure Disorders Drug Segment by Application
2.4.1 Hypertension
2.4.2 Hypotension
2.4.3 Pulmonary Hypertension
2.5 Blood Pressure Disorders Drug Market Size by Application
2.5.1 Blood Pressure Disorders Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Blood Pressure Disorders Drug Market Size Market Share by Application (2017-2022)
3 Blood Pressure Disorders Drug Market Size by Player
3.1 Blood Pressure Disorders Drug Market Size Market Share by Players
3.1.1 Global Blood Pressure Disorders Drug Revenue by Players (2020-2022)
3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2020-2022)
3.2 Global Blood Pressure Disorders Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Blood Pressure Disorders Drug by Regions
4.1 Blood Pressure Disorders Drug Market Size by Regions (2017-2022)
4.2 Americas Blood Pressure Disorders Drug Market Size Growth (2017-2022)
4.3 APAC Blood Pressure Disorders Drug Market Size Growth (2017-2022)
4.4 Europe Blood Pressure Disorders Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Blood Pressure Disorders Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Blood Pressure Disorders Drug Market Size by Country (2017-2022)
5.2 Americas Blood Pressure Disorders Drug Market Size by Type (2017-2022)
5.3 Americas Blood Pressure Disorders Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Pressure Disorders Drug Market Size by Region (2017-2022)
6.2 APAC Blood Pressure Disorders Drug Market Size by Type (2017-2022)
6.3 APAC Blood Pressure Disorders Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Blood Pressure Disorders Drug by Country (2017-2022)
7.2 Europe Blood Pressure Disorders Drug Market Size by Type (2017-2022)
7.3 Europe Blood Pressure Disorders Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood Pressure Disorders Drug by Region (2017-2022)
8.2 Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Blood Pressure Disorders Drug Market Forecast
10.1 Global Blood Pressure Disorders Drug Forecast by Regions (2023-2028)
10.1.1 Global Blood Pressure Disorders Drug Forecast by Regions (2023-2028)
10.1.2 Americas Blood Pressure Disorders Drug Forecast
10.1.3 APAC Blood Pressure Disorders Drug Forecast
10.1.4 Europe Blood Pressure Disorders Drug Forecast
10.1.5 Middle East & Africa Blood Pressure Disorders Drug Forecast
10.2 Americas Blood Pressure Disorders Drug Forecast by Country (2023-2028)
10.2.1 United States Blood Pressure Disorders Drug Market Forecast
10.2.2 Canada Blood Pressure Disorders Drug Market Forecast
10.2.3 Mexico Blood Pressure Disorders Drug Market Forecast
10.2.4 Brazil Blood Pressure Disorders Drug Market Forecast
10.3 APAC Blood Pressure Disorders Drug Forecast by Region (2023-2028)
10.3.1 China Blood Pressure Disorders Drug Market Forecast
10.3.2 Japan Blood Pressure Disorders Drug Market Forecast
10.3.3 Korea Blood Pressure Disorders Drug Market Forecast
10.3.4 Southeast Asia Blood Pressure Disorders Drug Market Forecast
10.3.5 India Blood Pressure Disorders Drug Market Forecast
10.3.6 Australia Blood Pressure Disorders Drug Market Forecast
10.4 Europe Blood Pressure Disorders Drug Forecast by Country (2023-2028)
10.4.1 Germany Blood Pressure Disorders Drug Market Forecast
10.4.2 France Blood Pressure Disorders Drug Market Forecast
10.4.3 UK Blood Pressure Disorders Drug Market Forecast
10.4.4 Italy Blood Pressure Disorders Drug Market Forecast
10.4.5 Russia Blood Pressure Disorders Drug Market Forecast
10.5 Middle East & Africa Blood Pressure Disorders Drug Forecast by Region (2023-2028)
10.5.1 Egypt Blood Pressure Disorders Drug Market Forecast
10.5.2 South Africa Blood Pressure Disorders Drug Market Forecast
10.5.3 Israel Blood Pressure Disorders Drug Market Forecast
10.5.4 Turkey Blood Pressure Disorders Drug Market Forecast
10.5.5 GCC Countries Blood Pressure Disorders Drug Market Forecast
10.6 Global Blood Pressure Disorders Drug Forecast by Type (2023-2028)
10.7 Global Blood Pressure Disorders Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 A1M Pharma AB
11.1.1 A1M Pharma AB Company Information
11.1.2 A1M Pharma AB Blood Pressure Disorders Drug Product Offered
11.1.3 A1M Pharma AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 A1M Pharma AB Main Business Overview
11.1.5 A1M Pharma AB Latest Developments
11.2 Acceleron Pharma Inc
11.2.1 Acceleron Pharma Inc Company Information
11.2.2 Acceleron Pharma Inc Blood Pressure Disorders Drug Product Offered
11.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Acceleron Pharma Inc Main Business Overview
11.2.5 Acceleron Pharma Inc Latest Developments
11.3 Ache Laboratorios Farmaceuticos SA
11.3.1 Ache Laboratorios Farmaceuticos SA Company Information
11.3.2 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product Offered
11.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ache Laboratorios Farmaceuticos SA Main Business Overview
11.3.5 Ache Laboratorios Farmaceuticos SA Latest Developments
11.4 Actelion Pharmaceuticals Ltd
11.4.1 Actelion Pharmaceuticals Ltd Company Information
11.4.2 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product Offered
11.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Actelion Pharmaceuticals Ltd Main Business Overview
11.4.5 Actelion Pharmaceuticals Ltd Latest Developments
11.5 Aerogen Ltd
11.5.1 Aerogen Ltd Company Information
11.5.2 Aerogen Ltd Blood Pressure Disorders Drug Product Offered
11.5.3 Aerogen Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Aerogen Ltd Main Business Overview
11.5.5 Aerogen Ltd Latest Developments
11.6 Anavex Life Sciences Corp
11.6.1 Anavex Life Sciences Corp Company Information
11.6.2 Anavex Life Sciences Corp Blood Pressure Disorders Drug Product Offered
11.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Anavex Life Sciences Corp Main Business Overview
11.6.5 Anavex Life Sciences Corp Latest Developments
11.7 AnGes Inc
11.7.1 AnGes Inc Company Information
11.7.2 AnGes Inc Blood Pressure Disorders Drug Product Offered
11.7.3 AnGes Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 AnGes Inc Main Business Overview
11.7.5 AnGes Inc Latest Developments
11.8 Arena Pharmaceuticals Inc
11.8.1 Arena Pharmaceuticals Inc Company Information
11.8.2 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product Offered
11.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Arena Pharmaceuticals Inc Main Business Overview
11.8.5 Arena Pharmaceuticals Inc Latest Developments
11.9 Ascendia Pharmaceuticals LLC
11.9.1 Ascendia Pharmaceuticals LLC Company Information
11.9.2 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product Offered
11.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ascendia Pharmaceuticals LLC Main Business Overview
11.9.5 Ascendia Pharmaceuticals LLC Latest Developments
11.10 Ascendis Pharma A/S
11.10.1 Ascendis Pharma A/S Company Information
11.10.2 Ascendis Pharma A/S Blood Pressure Disorders Drug Product Offered
11.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ascendis Pharma A/S Main Business Overview
11.10.5 Ascendis Pharma A/S Latest Developments
11.11 AVEO Pharmaceuticals Inc
11.11.1 AVEO Pharmaceuticals Inc Company Information
11.11.2 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product Offered
11.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AVEO Pharmaceuticals Inc Main Business Overview
11.11.5 AVEO Pharmaceuticals Inc Latest Developments
11.12 Bayer AG
11.12.1 Bayer AG Company Information
11.12.2 Bayer AG Blood Pressure Disorders Drug Product Offered
11.12.3 Bayer AG Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bayer AG Main Business Overview
11.12.5 Bayer AG Latest Developments
11.13 Bial - Portela & Ca SA
11.13.1 Bial - Portela & Ca SA Company Information
11.13.2 Bial - Portela & Ca SA Blood Pressure Disorders Drug Product Offered
11.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Bial - Portela & Ca SA Main Business Overview
11.13.5 Bial - Portela & Ca SA Latest Developments
11.14 Bioblue Technologies Inc
11.14.1 Bioblue Technologies Inc Company Information
11.14.2 Bioblue Technologies Inc Blood Pressure Disorders Drug Product Offered
11.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Bioblue Technologies Inc Main Business Overview
11.14.5 Bioblue Technologies Inc Latest Developments
11.15 Biogen Inc
11.15.1 Biogen Inc Company Information
11.15.2 Biogen Inc Blood Pressure Disorders Drug Product Offered
11.15.3 Biogen Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Biogen Inc Main Business Overview
11.15.5 Biogen Inc Latest Developments
11.16 Biolab Farmaceutica Ltda
11.16.1 Biolab Farmaceutica Ltda Company Information
11.16.2 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product Offered
11.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Biolab Farmaceutica Ltda Main Business Overview
11.16.5 Biolab Farmaceutica Ltda Latest Developments
11.17 BioRestorative Therapies Inc
11.17.1 BioRestorative Therapies Inc Company Information
11.17.2 BioRestorative Therapies Inc Blood Pressure Disorders Drug Product Offered
11.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 BioRestorative Therapies Inc Main Business Overview
11.17.5 BioRestorative Therapies Inc Latest Developments
11.18 Boryung Pharmaceutical Co Ltd
11.18.1 Boryung Pharmaceutical Co Ltd Company Information
11.18.2 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product Offered
11.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Boryung Pharmaceutical Co Ltd Main Business Overview
11.18.5 Boryung Pharmaceutical Co Ltd Latest Developments
11.19 Bristol-Myers Squibb Co
11.19.1 Bristol-Myers Squibb Co Company Information
11.19.2 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product Offered
11.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Bristol-Myers Squibb Co Main Business Overview
11.19.5 Bristol-Myers Squibb Co Latest Developments
11.20 Camurus AB
11.20.1 Camurus AB Company Information
11.20.2 Camurus AB Blood Pressure Disorders Drug Product Offered
11.20.3 Camurus AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Camurus AB Main Business Overview
11.20.5 Camurus AB Latest Developments
11.21 Capricor Therapeutics Inc
11.21.1 Capricor Therapeutics Inc Company Information
11.21.2 Capricor Therapeutics Inc Blood Pressure Disorders Drug Product Offered
11.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Capricor Therapeutics Inc Main Business Overview
11.21.5 Capricor Therapeutics Inc Latest Developments
11.22 Celsion Corp
11.22.1 Celsion Corp Company Information
11.22.2 Celsion Corp Blood Pressure Disorders Drug Product Offered
11.22.3 Celsion Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Celsion Corp Main Business Overview
11.22.5 Celsion Corp Latest Developments
11.23 Celtaxsys Inc
11.23.1 Celtaxsys Inc Company Information
11.23.2 Celtaxsys Inc Blood Pressure Disorders Drug Product Offered
11.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Celtaxsys Inc Main Business Overview
11.23.5 Celtaxsys Inc Latest Developments
11.24 Chiesi Farmaceutici SpA
11.24.1 Chiesi Farmaceutici SpA Company Information
11.24.2 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product Offered
11.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Chiesi Farmaceutici SpA Main Business Overview
11.24.5 Chiesi Farmaceutici SpA Latest Developments
11.25 Chong Kun Dang Pharmaceutical Corp
11.25.1 Chong Kun Dang Pharmaceutical Corp Company Information
11.25.2 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product Offered
11.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Chong Kun Dang Pharmaceutical Corp Main Business Overview
11.25.5 Chong Kun Dang Pharmaceutical Corp Latest Developments
11.26 Chugai Pharmaceutical Co Ltd
11.26.1 Chugai Pharmaceutical Co Ltd Company Information
11.26.2 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product Offered
11.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Chugai Pharmaceutical Co Ltd Main Business Overview
11.26.5 Chugai Pharmaceutical Co Ltd Latest Developments
11.27 CJ HealthCare Corp
11.27.1 CJ HealthCare Corp Company Information
11.27.2 CJ HealthCare Corp Blood Pressure Disorders Drug Product Offered
11.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 CJ HealthCare Corp Main Business Overview
11.27.5 CJ HealthCare Corp Latest Developments
11.28 Complexa Inc
11.28.1 Complexa Inc Company Information
11.28.2 Complexa Inc Blood Pressure Disorders Drug Product Offered
11.28.3 Complexa Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Complexa Inc Main Business Overview
11.28.5 Complexa Inc Latest Developments
11.29 Corion Biotech Srl
11.29.1 Corion Biotech Srl Company Information
11.29.2 Corion Biotech Srl Blood Pressure Disorders Drug Product Offered
11.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 Corion Biotech Srl Main Business Overview
11.29.5 Corion Biotech Srl Latest Developments
12 Research Findings and Conclusion
Table 1. Blood Pressure Disorders Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diuretics
Table 3. Major Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 4. Major Players of Angiotensin Receptor Blockers (ARBs)
Table 5. Major Players of Others
Table 6. Blood Pressure Disorders Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Blood Pressure Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Blood Pressure Disorders Drug Market Size Market Share by Type (2017-2022)
Table 9. Blood Pressure Disorders Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Blood Pressure Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Blood Pressure Disorders Drug Market Size Market Share by Application (2017-2022)
Table 12. Global Blood Pressure Disorders Drug Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Blood Pressure Disorders Drug Revenue Market Share by Player (2020-2022)
Table 14. Blood Pressure Disorders Drug Key Players Head office and Products Offered
Table 15. Blood Pressure Disorders Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Blood Pressure Disorders Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Blood Pressure Disorders Drug Market Size Market Share by Regions (2017-2022)
Table 20. Americas Blood Pressure Disorders Drug Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Blood Pressure Disorders Drug Market Size Market Share by Country (2017-2022)
Table 22. Americas Blood Pressure Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Blood Pressure Disorders Drug Market Size Market Share by Type (2017-2022)
Table 24. Americas Blood Pressure Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Blood Pressure Disorders Drug Market Size Market Share by Application (2017-2022)
Table 26. APAC Blood Pressure Disorders Drug Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Blood Pressure Disorders Drug Market Size Market Share by Region (2017-2022)
Table 28. APAC Blood Pressure Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Blood Pressure Disorders Drug Market Size Market Share by Type (2017-2022)
Table 30. APAC Blood Pressure Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Blood Pressure Disorders Drug Market Size Market Share by Application (2017-2022)
Table 32. Europe Blood Pressure Disorders Drug Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Blood Pressure Disorders Drug Market Size Market Share by Country (2017-2022)
Table 34. Europe Blood Pressure Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Blood Pressure Disorders Drug Market Size Market Share by Type (2017-2022)
Table 36. Europe Blood Pressure Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Blood Pressure Disorders Drug Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Blood Pressure Disorders Drug Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Blood Pressure Disorders Drug Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Blood Pressure Disorders Drug Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Blood Pressure Disorders Drug Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Blood Pressure Disorders Drug
Table 45. Key Market Challenges & Risks of Blood Pressure Disorders Drug
Table 46. Key Industry Trends of Blood Pressure Disorders Drug
Table 47. Global Blood Pressure Disorders Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Blood Pressure Disorders Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Blood Pressure Disorders Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Blood Pressure Disorders Drug Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Blood Pressure Disorders Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Blood Pressure Disorders Drug Market Size Market Share Forecast by Application (2023-2028)
Table 53. A1M Pharma AB Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 54. A1M Pharma AB Blood Pressure Disorders Drug Product Offered
Table 55. A1M Pharma AB Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. A1M Pharma AB Main Business
Table 57. A1M Pharma AB Latest Developments
Table 58. Acceleron Pharma Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 59. Acceleron Pharma Inc Blood Pressure Disorders Drug Product Offered
Table 60. Acceleron Pharma Inc Main Business
Table 61. Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Acceleron Pharma Inc Latest Developments
Table 63. Ache Laboratorios Farmaceuticos SA Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 64. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product Offered
Table 65. Ache Laboratorios Farmaceuticos SA Main Business
Table 66. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Ache Laboratorios Farmaceuticos SA Latest Developments
Table 68. Actelion Pharmaceuticals Ltd Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 69. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product Offered
Table 70. Actelion Pharmaceuticals Ltd Main Business
Table 71. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Actelion Pharmaceuticals Ltd Latest Developments
Table 73. Aerogen Ltd Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 74. Aerogen Ltd Blood Pressure Disorders Drug Product Offered
Table 75. Aerogen Ltd Main Business
Table 76. Aerogen Ltd Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Aerogen Ltd Latest Developments
Table 78. Anavex Life Sciences Corp Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 79. Anavex Life Sciences Corp Blood Pressure Disorders Drug Product Offered
Table 80. Anavex Life Sciences Corp Main Business
Table 81. Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Anavex Life Sciences Corp Latest Developments
Table 83. AnGes Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 84. AnGes Inc Blood Pressure Disorders Drug Product Offered
Table 85. AnGes Inc Main Business
Table 86. AnGes Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. AnGes Inc Latest Developments
Table 88. Arena Pharmaceuticals Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 89. Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product Offered
Table 90. Arena Pharmaceuticals Inc Main Business
Table 91. Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Arena Pharmaceuticals Inc Latest Developments
Table 93. Ascendia Pharmaceuticals LLC Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 94. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product Offered
Table 95. Ascendia Pharmaceuticals LLC Main Business
Table 96. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Ascendia Pharmaceuticals LLC Latest Developments
Table 98. Ascendis Pharma A/S Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 99. Ascendis Pharma A/S Blood Pressure Disorders Drug Product Offered
Table 100. Ascendis Pharma A/S Main Business
Table 101. Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Ascendis Pharma A/S Latest Developments
Table 103. AVEO Pharmaceuticals Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 104. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product Offered
Table 105. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. AVEO Pharmaceuticals Inc Main Business
Table 107. AVEO Pharmaceuticals Inc Latest Developments
Table 108. Bayer AG Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 109. Bayer AG Blood Pressure Disorders Drug Product Offered
Table 110. Bayer AG Main Business
Table 111. Bayer AG Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Bayer AG Latest Developments
Table 113. Bial - Portela & Ca SA Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 114. Bial - Portela & Ca SA Blood Pressure Disorders Drug Product Offered
Table 115. Bial - Portela & Ca SA Main Business
Table 116. Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Bial - Portela & Ca SA Latest Developments
Table 118. Bioblue Technologies Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 119. Bioblue Technologies Inc Blood Pressure Disorders Drug Product Offered
Table 120. Bioblue Technologies Inc Main Business
Table 121. Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Bioblue Technologies Inc Latest Developments
Table 123. Biogen Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 124. Biogen Inc Blood Pressure Disorders Drug Product Offered
Table 125. Biogen Inc Main Business
Table 126. Biogen Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Biogen Inc Latest Developments
Table 128. Biolab Farmaceutica Ltda Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 129. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product Offered
Table 130. Biolab Farmaceutica Ltda Main Business
Table 131. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. Biolab Farmaceutica Ltda Latest Developments
Table 133. BioRestorative Therapies Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 134. BioRestorative Therapies Inc Blood Pressure Disorders Drug Product Offered
Table 135. BioRestorative Therapies Inc Main Business
Table 136. BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. BioRestorative Therapies Inc Latest Developments
Table 138. Boryung Pharmaceutical Co Ltd Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 139. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product Offered
Table 140. Boryung Pharmaceutical Co Ltd Main Business
Table 141. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 142. Boryung Pharmaceutical Co Ltd Latest Developments
Table 143. Bristol-Myers Squibb Co Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 144. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product Offered
Table 145. Bristol-Myers Squibb Co Main Business
Table 146. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 147. Bristol-Myers Squibb Co Latest Developments
Table 148. Camurus AB Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 149. Camurus AB Blood Pressure Disorders Drug Product Offered
Table 150. Camurus AB Main Business
Table 151. Camurus AB Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 152. Camurus AB Latest Developments
Table 153. Capricor Therapeutics Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 154. Capricor Therapeutics Inc Blood Pressure Disorders Drug Product Offered
Table 155. Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 156. Capricor Therapeutics Inc Main Business
Table 157. Capricor Therapeutics Inc Latest Developments
Table 158. Celsion Corp Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 159. Celsion Corp Blood Pressure Disorders Drug Product Offered
Table 160. Celsion Corp Main Business
Table 161. Celsion Corp Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 162. Celsion Corp Latest Developments
Table 163. Celtaxsys Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 164. Celtaxsys Inc Blood Pressure Disorders Drug Product Offered
Table 165. Celtaxsys Inc Main Business
Table 166. Celtaxsys Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 167. Celtaxsys Inc Latest Developments
Table 168. Chiesi Farmaceutici SpA Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 169. Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product Offered
Table 170. Chiesi Farmaceutici SpA Main Business
Table 171. Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 172. Chiesi Farmaceutici SpA Latest Developments
Table 173. Chong Kun Dang Pharmaceutical Corp Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 174. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product Offered
Table 175. Chong Kun Dang Pharmaceutical Corp Main Business
Table 176. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 177. Chong Kun Dang Pharmaceutical Corp Latest Developments
Table 178. Chugai Pharmaceutical Co Ltd Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 179. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product Offered
Table 180. Chugai Pharmaceutical Co Ltd Main Business
Table 181. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 182. Chugai Pharmaceutical Co Ltd Latest Developments
Table 183. CJ HealthCare Corp Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 184. CJ HealthCare Corp Blood Pressure Disorders Drug Product Offered
Table 185. CJ HealthCare Corp Main Business
Table 186. CJ HealthCare Corp Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 187. CJ HealthCare Corp Latest Developments
Table 188. Complexa Inc Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 189. Complexa Inc Blood Pressure Disorders Drug Product Offered
Table 190. Complexa Inc Main Business
Table 191. Complexa Inc Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 192. Complexa Inc Latest Developments
Table 193. Corion Biotech Srl Details, Company Type, Blood Pressure Disorders Drug Area Served and Its Competitors
Table 194. Corion Biotech Srl Blood Pressure Disorders Drug Product Offered
Table 195. Corion Biotech Srl Main Business
Table 196. Corion Biotech Srl Blood Pressure Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 197. Corion Biotech Srl Latest Developments
List of Figures
Figure 1. Blood Pressure Disorders Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Pressure Disorders Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Blood Pressure Disorders Drug Market Size Market Share by Type in 2021
Figure 7. Blood Pressure Disorders Drug in Hypertension
Figure 8. Global Blood Pressure Disorders Drug Market: Hypertension (2017-2022) & ($ Millions)
Figure 9. Blood Pressure Disorders Drug in Hypotension
Figure 10. Global Blood Pressure Disorders Drug Market: Hypotension (2017-2022) & ($ Millions)
Figure 11. Blood Pressure Disorders Drug in Pulmonary Hypertension
Figure 12. Global Blood Pressure Disorders Drug Market: Pulmonary Hypertension (2017-2022) & ($ Millions)
Figure 13. Global Blood Pressure Disorders Drug Market Size Market Share by Application in 2021
Figure 14. Global Blood Pressure Disorders Drug Revenue Market Share by Player in 2021
Figure 15. Global Blood Pressure Disorders Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Blood Pressure Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Blood Pressure Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Blood Pressure Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Blood Pressure Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Blood Pressure Disorders Drug Value Market Share by Country in 2021
Figure 21. Americas Blood Pressure Disorders Drug Consumption Market Share by Type in 2021
Figure 22. Americas Blood Pressure Disorders Drug Market Size Market Share by Application in 2021
Figure 23. United States Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Blood Pressure Disorders Drug Market Size Market Share by Region in 2021
Figure 28. APAC Blood Pressure Disorders Drug Market Size Market Share by Application in 2021
Figure 29. China Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Blood Pressure Disorders Drug Market Size Market Share by Country in 2021
Figure 36. Europe Blood Pressure Disorders Drug Market Size Market Share by Type in 2021
Figure 37. Europe Blood Pressure Disorders Drug Market Size Market Share by Application in 2021
Figure 38. Germany Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Blood Pressure Disorders Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Blood Pressure Disorders Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Blood Pressure Disorders Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Blood Pressure Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Blood Pressure Disorders Drug Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...